Bibliography
Kaporis, H. G., Guttman-Yassky, E., Lowes, M. A., Haider, A. S., Fuentes-Duculan, J., Darabi, K., Whynot-Ertelt, J., Khatcherian, A., Cardinale, I., Novitskaya, I., Krueger, J. G., & Carucci, J. A. (2007). Human Basal Cell Carcinoma Is Associated with Foxp3+ T cells in a Th2 Dominant Microenvironment. Journal of Investigative Dermatology, 127(10), 2391â2398.
Authors
12
- Helen G. Kaporis (first)
- Emma Guttman-Yassky (additional)
- Michelle A. Lowes (additional)
- Asifa S. Haider (additional)
- Judilyn Fuentes-Duculan (additional)
- Kamruz Darabi (additional)
- Julia Whynot-Ertelt (additional)
- Artemis Khatcherian (additional)
- Irma Cardinale (additional)
- Inna Novitskaya (additional)
- James G. Krueger (additional)
- John A. Carucci (additional)
References
32
Referenced
99
10.1097/00000372-198712000-00001
/ Am J Dermatopathol / Perturbation of epidermal Langerhans cells in basal cell carcinomas by Azizi (1987)10.1182/blood-2006-03-011353
/ Blood / Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Banerjee (2006)10.1182/blood.V99.8.2929
/ Blood / The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells by Berger (2002)10.1182/blood-2005-09-3671
/ Blood / In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma by Beyer (2006)10.1182/blood-2006-02-002774
/ Blood / Regulatory T cells in cancer by Beyer (2006)10.1016/S1359-6101(01)00032-6
/ Cytokine Growth Factor Rev / Interleukin-12 in anti-tumor immunity and immunotherapy by Colombo (2002)10.1038/nm1093
/ Nat Med / Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival by Curiel (2004)10.4049/jimmunol.154.9.4851
/ J Immunol / Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro by Enk (1995)10.1006/mthe.2000.0221
/ Mol Ther / Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors by Garcia-Castro (2001)10.1016/j.jaad.2003.11.066
/ J Am Acad Dermatol / Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies by Geisse (2004)10.1038/sj.jid.5700157
/ J Invest Dermatol / Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia by Haider (2006)10.4049/jimmunol.176.9.5293
/ J Immunol / Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation by Houot (2006)10.4049/jimmunol.155.4.2240
/ J Immunol / IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response by Kim (1995)10.1084/jem.20041709
/ J Exp Med / Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor by Lee (2005){'key': '10.1038/sj.jid.5700884_bb0080', 'first-page': '641', 'article-title': 'Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells', 'volume': '150', 'author': 'Nestle', 'year': '1997', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells by Nestle (1997)10.1182/blood-2005-08-3141
/ Blood / Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features by Rutella (2006)10.1182/blood-2006-03-006403
/ Blood / Tolerogenic dendritic cells: cytokine modulation comes of age by Rutella (2006)10.1016/j.imlet.2004.04.015
/ Immunol Lett / Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications by Rutella (2004)10.1093/jnci/djg016
/ J Natl Cancer Inst / Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod by Schon (2003){'key': '10.1038/sj.jid.5700884_bb0105', 'first-page': '79', 'article-title': 'Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice', 'volume': '24', 'author': 'Shan', 'year': '2004', 'journal-title': 'Anticancer Res'}
/ Anticancer Res / Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice by Shan (2004){'key': '10.1038/sj.jid.5700884_bb0110', 'first-page': '47', 'article-title': 'Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells', 'volume': '3', 'author': 'Shan', 'year': '2006', 'journal-title': 'Cell Mol Immunol'}
/ Cell Mol Immunol / Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells by Shan (2006)10.1046/j.1365-2230.2002.01151.x
/ Clin Exp Dermatol / Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential by Stanley (2002){'key': '10.1038/sj.jid.5700884_bb0120', 'first-page': '1', 'article-title': 'The interaction of immunodeficiency viruses with dendritic cells', 'volume': '276', 'author': 'Steinman', 'year': '2003', 'journal-title': 'Curr Top Microbiol Immunol'}
/ Curr Top Microbiol Immunol / The interaction of immunodeficiency viruses with dendritic cells by Steinman (2003)10.1182/blood-2006-01-007187
/ Blood / Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10 by Tang (2006)10.1016/j.jaad.2006.02.035
/ J Am Acad Dermatol / Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy by Tucker (2006)10.1093/jnci/dji207
/ J Natl Cancer Inst / Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment by Urosevic (2005)10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L
/ Eur J Immunol / Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo by Vulcano (2001)10.1111/j.0303-6987.2005.00297.x
/ J Cutan Pathol / Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod by Wenzel (2005)10.1046/j.1365-2133.2000.03596.x
/ Br J Dermatol / Cytokine profiles in spontaneously regressing basal cell carcinomas by Wong (2000)10.1182/blood-2005-08-3376
/ Blood / Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma by Yang (2006)10.1152/physiolgenomics.00157.2002
/ Physiol Genomics / Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array by Zhou (2003)10.1038/nri1936
/ Nat Rev Immunol / Cancer despite immunosurveillance: immunoselection and immunosubversion by Zitvogel (2006)
Dates
Type | When |
---|---|
Created | 18 years, 3 months ago (May 17, 2007, 12:39 p.m.) |
Deposited | 2 years, 3 months ago (May 11, 2023, 6:11 p.m.) |
Indexed | 1 month ago (July 22, 2025, 6:37 a.m.) |
Issued | 17 years, 10 months ago (Oct. 1, 2007) |
Published | 17 years, 10 months ago (Oct. 1, 2007) |
Published Print | 17 years, 10 months ago (Oct. 1, 2007) |
@article{Kaporis_2007, title={Human Basal Cell Carcinoma Is Associated with Foxp3+ T cells in a Th2 Dominant Microenvironment}, volume={127}, ISSN={0022-202X}, url={http://dx.doi.org/10.1038/sj.jid.5700884}, DOI={10.1038/sj.jid.5700884}, number={10}, journal={Journal of Investigative Dermatology}, publisher={Elsevier BV}, author={Kaporis, Helen G. and Guttman-Yassky, Emma and Lowes, Michelle A. and Haider, Asifa S. and Fuentes-Duculan, Judilyn and Darabi, Kamruz and Whynot-Ertelt, Julia and Khatcherian, Artemis and Cardinale, Irma and Novitskaya, Inna and Krueger, James G. and Carucci, John A.}, year={2007}, month=oct, pages={2391–2398} }